Su X - Search Results

1

ScRNA-seq and spatial transcriptomics: exploring the occurrence and treatment of coronary-related diseases starting from development.

Liu C, Yang F, Su X, Zhang Z, Xing Y. Liu C, et al. Among authors: su x. Front Cardiovasc Med. 2023 Jun 20;10:1064949. doi: 10.3389/fcvm.2023.1064949. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37416923 Free PMC article. Review.

2

Cytoplasmic Ca2+ inhibits the glucose transporter of human erythrocytes.

Tu YP, Xiao L, Su XF, Yang FY. Tu YP, et al. Among authors: su xf. Biochem Mol Biol Int. 1995 Jun;36(2):383-91. Biochem Mol Biol Int. 1995. PMID: 7663442

3

The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases.

Su X, Yuan C, Wang L, Chen R, Li X, Zhang Y, Liu C, Liu X, Liang W, Xing Y. Su X, et al. Oxid Med Cell Longev. 2021 Jan 19;2021:6699821. doi: 10.1155/2021/6699821. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33542784 Free PMC article. Review.

4

Cardioprotective effect of saffron total glycoside tablets in patients with breast cancer receiving anthracycline-based chemotherapy: study protocol for a multicentre, randomised, parallel, double-blind, placebo-controlled clinical trial.

Su X, Li XY, Zhang YJ, Liu YS, Yuan C, Yang F, Liu C, Chen HW, Xiong XJ, Gao YH, Xing YW. Su X, et al. Ann Palliat Med. 2021 Jul;10(7):8283-8291. doi: 10.21037/apm-21-444. Epub 2021 Jun 26. Ann Palliat Med. 2021. PMID: 34263648 Free article.

5

Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.

Su X, Zhang X, Liu W, Yang X, An N, Yang F, Sun J, Xing Y, Shang H. Su X, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):929-942. doi: 10.1016/j.semcancer.2021.08.003. Epub 2021 Aug 8. Semin Cancer Biol. 2022. PMID: 34375726 Review.

6

Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials.

Pan X, Tian L, Yang F, Sun J, Li X, An N, Xing Y, Su X, Liu X, Liu C, Gao Y, Xing Y. Pan X, et al. Among authors: su x. Evid Based Complement Alternat Med. 2021 Sep 4;2021:4094325. doi: 10.1155/2021/4094325. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34527058 Free PMC article.

7

Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.

Li X, Ma N, Xu J, Zhang Y, Yang P, Su X, Xing Y, An N, Yang F, Zhang G, Zhang L, Xing Y. Li X, et al. Among authors: su x. Oxid Med Cell Longev. 2021 Oct 28;2021:1587922. doi: 10.1155/2021/1587922. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34745412 Free PMC article. Review.

8

Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments.

Liu C, Ma N, Guo Z, Zhang Y, Zhang J, Yang F, Su X, Zhang G, Xiong X, Xing Y. Liu C, et al. Among authors: su x. Pharmacol Res. 2022 Jan;175:106027. doi: 10.1016/j.phrs.2021.106027. Epub 2021 Dec 7. Pharmacol Res. 2022. PMID: 34890774 Review.

9

Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics.

Su X, Zhou M, Li Y, Zhang J, An N, Yang F, Zhang G, Yuan C, Chen H, Wu H, Xing Y. Su X, et al. Biomed Pharmacother. 2022 May;149:112893. doi: 10.1016/j.biopha.2022.112893. Epub 2022 Mar 31. Biomed Pharmacother. 2022. PMID: 35366532 Free article. Review.

10

Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products.

Su X, Zhou M, Li Y, An N, Yang F, Zhang G, Xu L, Chen H, Wu H, Xing Y. Su X, et al. Oxid Med Cell Longev. 2022 May 16;2022:8726564. doi: 10.1155/2022/8726564. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35615579 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,640 results

Search Page

Filters